Study on the Effect of Capacity Shock Intervention Under Goal-directed Hemodynamic Management on P-V Loop
1 other identifier
interventional
20
1 country
1
Brief Summary
By observing the changes of P-V loop in capacity shock intervention Under Goal-directed Hemodynamic Management in patients undergoing total knee replacement, we investigate the effect of capacity shock on cardiac contractility and work in order to seek a more effective target plan of capacity shock for intraoperative patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2021
CompletedFirst Submitted
Initial submission to the registry
May 25, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 10, 2021
CompletedFirst Posted
Study publicly available on registry
June 22, 2021
CompletedJune 22, 2021
June 1, 2021
11 months
May 25, 2021
June 19, 2021
Conditions
Outcome Measures
Primary Outcomes (15)
Ees
Ees(End-systole Elasticity,mmHg/ml)
Baseline,After induction
Ees
Ees(End-systole Elasticity,mmHg/ml)
Immediately after the intervention,complete of the first round of the fluid challenge
Ees
Arterial elasticity is an invasively determined parameter of arterial load that is inversely related to arterial compliance
Immediately after the intervention,complete of the second round of the fluid challenge
Ees
Ees(End-systole Elasticity,mmHg/ml)
1h after the first fluid challenge
Ees
Ees(End-systole Elasticity,mmHg/ml)
At the end of surgery
SW
SW(Stroke Volume,mmHg·ml)
Baseline,after induction
SW
SW(Stroke Volume,mmHg·ml)
Immediately after the intervention,complete of the first round of the fluid challenge
SW
SW(Stroke Volume,mmHg·ml)
Immediately after the intervention,complete of the second round of the fluid challenge
SW
SW(Stroke Volume,mmHg·ml)
1h after the first fluid challenge
SW
SW(Stroke Volume,mmHg·ml)
At the end of surgery
Ea
Ea(Arterial elasticity, mmHg·ml)
Baseline,after induction
Ea
Ea(Arterial elasticity, mmHg·ml)
Immediately after the intervention,complete of the first round of the fluid challenge
Ea
Ea(Arterial elasticity, mmHg·ml)
Immediately after the intervention,complete of the second round of the fluid challenge
Ea
Ea(Arterial elasticity, mmHg·ml)
1h after the first fluid challenge
Ea
Ea(Arterial elasticity, mmHg·ml)
At the end of surgery
Study Arms (2)
capacity shock
EXPERIMENTAL2ml/kg succinylateol gelatin
routine management
OTHERconventional strategy
Interventions
Patients received 2ml/kg of succinylateol gelatin within 10 min for fluid shock therapy after grouping, taking SVV as the management target. If SVV\< 13% after shock therapy, the shock therapy was stopped and the infusion was maintained with 4ml/kg/h of crystal solution. If SVV ≥ 13% and ΔSV \<10%, the individual would be excluded from the experiment. If SVV ≥ 13% but ΔSV≥10%, 2ml/kg of succinylateol gelatin was given again within 10 min for liquid shock therapy until SVV\<13%, and 4ml/kg/h of crystal solution was maintained after reaching the target. If SVV≥ 13% after two shock treatments, they were excluded from the experiment. We excluded patients whose intraoperative bleeding ≥400ml and operative time ≥5 hours from the group.
4ml/kg/h of crystal solution was maintained. We excluded patients whose intraoperative bleeding ≥400ml and operative time ≥5 hours from the group.
Eligibility Criteria
You may qualify if:
- ASAI-II age 40- 70 weight 48 - 72 kg.
You may not qualify if:
- Body mass index \>30 or \<15 kg/m2 Valve heart disease Left ventricular ejection fraction (LVEF) is less than 50% History of lung disease Preoperative arrhythmic disorder Permanent pacemaker Need for mechanical heart Support, Severe extrinsic vascular disease Valve dysfunction OED monitoring probe insertion contraindications Patients with preoperative assessments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Guangzhou Red cross hospital
Guangzhou, Guangdong, 510220, China
Study Officials
- STUDY DIRECTOR
Cao Yang
Guangzhou Red Cross Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Deputy Director of Anesthesiology Physicians
Study Record Dates
First Submitted
May 25, 2021
First Posted
June 22, 2021
Study Start
June 1, 2020
Primary Completion
May 1, 2021
Study Completion
June 10, 2021
Last Updated
June 22, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share